Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Parikh

Showing results (361-370 of 399) with videos related to

Pageof 40
Sort By:
Journal of Medicinal Chemistry|August 16, 2019
Selective, Small-Molecule Co-Factor Binding Site Inhibition of a Su(var)3-9, Enhancer of Zeste, Trithorax Domain Containing Lysine MethyltransferaseAlexandria P Taylor, Magdalena Swewczyk, Steven Kennedy, et al.
Surgery|May 29, 2026
Corrigendum to "Direct-acting antivirals lower mortality and recurrence in HCV-related hepatocellular carcinoma post liver resection: A multicenter international study" [Surgery 183 (2025) 109396]Woo Jin Choi, Tommy Ivanics, Marco Claasen, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 20, 2026
Values-Based Healthcare and the Quintuple Aim: Connection, Compassion, Equity, & StewardshipAshish D Parikh, Lisa Barisciano, Marylee Verdi, et al.
Surgery|May 7, 2025
Direct-acting antivirals lower mortality and recurrence in HCV-related hepatocellular carcinoma post liver resection: A multicenter international studyWoo Jin Choi, Tommy Ivanics, Marco Claasen, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Structure-Based Design of Irreversible Human KAT II Inhibitors: Discovery of New Potency-Enhancing InteractionsJamison B Tuttle, Marie Anderson, Bruce M Bechle, et al.
Liver Cancer|October 9, 2025
Curative Treatment after Immunotherapy Leads to Excellent Outcomes in Patients with Hepatocellular CarcinomaGwang Hyeon Choi, Hyun-Seok Kim, Michael Luu, et al.
JHEP Reports : Innovation in Hepatology|June 30, 2025
The association between stage migration and overall survival after radiation-based therapies in patients with hepatocellular carcinomaSuraj Pai, Amit G Singal, Shengchen Hao, et al.
Hepatology (Baltimore, Md.)|April 22, 2025
AI-based phenotyping of hepatic fiber morphology to inform molecular alterations in metabolic dysfunction-associated steatotic liver diseaseNaoto Fujiwara, Yuki Matsushita, Mina Tempaku, et al.
Bioorganic & Medicinal Chemistry Letters|February 18, 1999
Inhibition of MMP-1 and MMP-13 with phosphinic acids that exploit binding in the S2 pocketL A Reiter, J P Rizzi, J Pandit, et al.
The American Journal of Gastroenterology|July 17, 2024
The Liver Cirrhosis Network Cohort Study: Cirrhosis Definition, Study Population, and EndpointsElliot B Tapper, David Goldberg, Neehar D Parikh, et al.
Pageof 40

Showing results (361-370 of 399) with videos related to

Sort By:
Pageof 40
Journal of Medicinal Chemistry|August 16, 2019
Selective, Small-Molecule Co-Factor Binding Site Inhibition of a Su(var)3-9, Enhancer of Zeste, Trithorax Domain Containing Lysine MethyltransferaseAlexandria P Taylor, Magdalena Swewczyk, Steven Kennedy, et al.
Surgery|May 29, 2026
Corrigendum to "Direct-acting antivirals lower mortality and recurrence in HCV-related hepatocellular carcinoma post liver resection: A multicenter international study" [Surgery 183 (2025) 109396]Woo Jin Choi, Tommy Ivanics, Marco Claasen, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 20, 2026
Values-Based Healthcare and the Quintuple Aim: Connection, Compassion, Equity, & StewardshipAshish D Parikh, Lisa Barisciano, Marylee Verdi, et al.
Surgery|May 7, 2025
Direct-acting antivirals lower mortality and recurrence in HCV-related hepatocellular carcinoma post liver resection: A multicenter international studyWoo Jin Choi, Tommy Ivanics, Marco Claasen, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Structure-Based Design of Irreversible Human KAT II Inhibitors: Discovery of New Potency-Enhancing InteractionsJamison B Tuttle, Marie Anderson, Bruce M Bechle, et al.
Liver Cancer|October 9, 2025
Curative Treatment after Immunotherapy Leads to Excellent Outcomes in Patients with Hepatocellular CarcinomaGwang Hyeon Choi, Hyun-Seok Kim, Michael Luu, et al.
JHEP Reports : Innovation in Hepatology|June 30, 2025
The association between stage migration and overall survival after radiation-based therapies in patients with hepatocellular carcinomaSuraj Pai, Amit G Singal, Shengchen Hao, et al.
Hepatology (Baltimore, Md.)|April 22, 2025
AI-based phenotyping of hepatic fiber morphology to inform molecular alterations in metabolic dysfunction-associated steatotic liver diseaseNaoto Fujiwara, Yuki Matsushita, Mina Tempaku, et al.
Bioorganic & Medicinal Chemistry Letters|February 18, 1999
Inhibition of MMP-1 and MMP-13 with phosphinic acids that exploit binding in the S2 pocketL A Reiter, J P Rizzi, J Pandit, et al.
The American Journal of Gastroenterology|July 17, 2024
The Liver Cirrhosis Network Cohort Study: Cirrhosis Definition, Study Population, and EndpointsElliot B Tapper, David Goldberg, Neehar D Parikh, et al.
Pageof 40